Global Cord Blood Co. (NYSE:CO - Get Free Report)'s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.02 and traded as high as $1.20. Global Cord Blood shares last traded at $1.20, with a volume of 3,150 shares changing hands.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen started coverage on shares of Global Cord Blood in a report on Saturday, May 17th. They set a "strong-buy" rating on the stock.
Check Out Our Latest Analysis on Global Cord Blood
Global Cord Blood Trading Up 5.0%
The stock has a market cap of $153.15 million, a price-to-earnings ratio of 1.97 and a beta of 0.16. The firm has a fifty day simple moving average of $0.98 and a 200 day simple moving average of $1.02.
About Global Cord Blood
(
Get Free Report)
Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.
Featured Articles
Before you consider Global Cord Blood, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Cord Blood wasn't on the list.
While Global Cord Blood currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
